Social Security Institution (SGK)) Presidency’s “Communiqué on Amending the Social Security Institution Health Implementation Communiqué” and “Health Services Pricing Commission Decision” were published in the duplicate issue of the Official Gazette.
Accordingly, 52 drugs registered in the “Pharmaceuticals List” attached to the SSI Health Implementation Communiqué (SUT) were excluded from the scope of reimbursement.
Although not included in the same list, topical drugs such as anti-inflammatory drugs, gels and ointments used in the treatment of joint-muscle pain, topical drugs such as pain relievers used during teething It was decided not to be included in the scope of payment.
Drug reimbursement applications made in these groups will also not be considered.
The base unit price application applied in determining the price to be paid for equivalent drugs was reduced from 10 percent to 5 percent.
On the other hand, with the change in the communiqué, oral and dental health treatments performed in private health service providers and dental units in official health service providers that do not have a contract with the institution, excluding orthodontic dental treatments and persons with a disability of 40 percent or more, will not be paid by the Institution.
On the Anadolu Agency website, news presented to subscribers via the AA News Flow System (HAS) is published in summary. ..